BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10711830)

  • 1. Pituitary-ovarian dysfunction and endometriosis.
    Cahill DJ; Hull MG
    Hum Reprod Update; 2000; 6(1):56-66. PubMed ID: 10711830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometriosis and infertility: the debate continues.
    Trinder J; Cahill DJ
    Hum Fertil (Camb); 2002 Feb; 5(1 Suppl):S21-7. PubMed ID: 11897911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of progestogen therapy on follicular development, related hormone concentrations and fertilization in vitro in unstimulated cycles and unexplained and endometriosis-associated infertility.
    Cahill DJ; Wardle PG; Harlow CR; Hull MG
    Hum Reprod; 1996 Mar; 11(3):647-50. PubMed ID: 8671284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary-ovarian dysfunction as a cause for endometriosis-associated and unexplained infertility.
    Cahill DJ; Wardle PG; Maile LA; Harlow CR; Hull MG
    Hum Reprod; 1995 Dec; 10(12):3142-46. PubMed ID: 8822432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular hormonal environment and embryo quality in women with endometriosis.
    Garrido N; Navarro J; Remohí J; Simón C; Pellicer A
    Hum Reprod Update; 2000; 6(1):67-74. PubMed ID: 10711831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility.
    Omland AK; Fedorcsák P; Storeng R; Dale PO; Abyholm T; Tanbo T
    Hum Reprod; 2001 Dec; 16(12):2587-92. PubMed ID: 11726579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian dysfunction in endometriosis-associated and unexplained infertility.
    Cahill DJ; Wardle PG; Maile LA; Harlow CR; Hull MG
    J Assist Reprod Genet; 1997 Nov; 14(10):554-7. PubMed ID: 9447453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of subtle oocyte or sperm dysfunction affecting fertilization in endometriosis-associated or unexplained infertility: a controlled comparison with tubal infertility and use of donor spermatozoa.
    Hull MG; Williams JA; Ray B; McLaughlin EA; Akande VA; Ford WC
    Hum Reprod; 1998 Jul; 13(7):1825-30. PubMed ID: 9740433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
    Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
    Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis.
    Al-Azemi M; Bernal AL; Steele J; Gramsbergen I; Barlow D; Kennedy S
    Hum Reprod; 2000 Jan; 15(1):72-5. PubMed ID: 10611191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-ovulatory granulosa cells of infertile women with endometriosis are less sensitive to luteinizing hormone.
    Cahill DJ; Harlow CR; Wardle PG
    Am J Reprod Immunol; 2003 Feb; 49(2):66-9. PubMed ID: 12765343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary-ovarian function in women with minimal or mild endometriosis and otherwise unexplained infertility.
    Bancroft K; Vaughan Williams CA; Elstein M
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):177-81. PubMed ID: 1568349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys.
    Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
    Hum Reprod; 1995 Jul; 10(7):1658-66. PubMed ID: 8582957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
    Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone.
    Develioglu OH; Cox B; Toner JP; Oehninger S; Muasher SJ
    Hum Reprod; 1999 May; 14(5):1168-74. PubMed ID: 10325255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
    Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
    Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.